| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Haematology [G. P. J., M. S., J. S. W.], Austin Hospital, Heidelberg, Melbourne, 3084, and Russell Grimwade School of Biochemistry [L. R. F.], University of Melbourne, Parkville, Melbourne, 3052, Australia
The intracellular half-life for retention of the active triphosphate metabolite 1-ß-D-arabinofuransylcytosine 5'-triphosphate (araCTP) of 1-ß-D-arabinofuranosylcytosine was measured in vitro in blast cells from patients with acute myeloblastic leukemia, acute lymphoblastic leukemia, and T-cell lymphoblastic lymphoma. araCTP accumulation from 1 µM 1-ß-D-arabinofuranosylcytosine in leukemic blast cells was closely correlated with the nucleoside transport capacity as measured by equilibrium binding of [3H]nitrobenzylthioinosine. The half-life of araCTP retention was related to araCTP accumulation only when the level of araCTP was expressed as a percentage of total intracellular 1-ß-D-arabinofuranosylcytosine metabolites. Accumulation of 1-ß-D-arabinofuranosyluracil 5'-monophosphate was inversely related to the half-life of araCTP retention and directly related to dCMP deaminase activity in cell free extracts. No conversion of 1-ß-D-arabinofuranosyluracil to 1-ß-D-arabinofuranosyluracil 5'-monophosphate was detectable in intact cells. The end product of araCTP degradation was 1-ß-D-arabinofuranosyluracil and it is proposed that conversion of 1-ß-D-arabinofuranosylcytosine 5'-monophosphate to 1-ß-D-arabinofuranosyluracil 5'-monophosphate is a step in the degradative pathway of araCTP. However, it is the cells' nucleoside transport capacity which primarily determines the level of intracellular araCTP accumulation.
1 This research was carried out during the tenure of a grant from the Anti Cancer Council of Victoria.
2 To whom requests for reprints should be addressed.
Received 11/25/85. Revised 2/ 4/87. Accepted 3/13/87.
This article has been cited by other articles:
![]() |
J.-Y. Liou, P. Krishnan, C.-C. Hsieh, G. E. Dutschman, and Y.-c. Cheng Assessment of the Effect of Phosphorylated Metabolites of Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Pyrimidine Analogs on the Behavior of Human Deoxycytidylate Deaminase Mol. Pharmacol., January 1, 2003; 63(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |